ライフサイエンスコーパス: high-grade

1 nalyzed: 141 (89%) low grade versus 17 (11%) high grade.

2 than 5 cm in diameter and of intermediate or high grade.

3 More than half of all DCIS lesions were high grade (52.6%; 393 of 747).

4 ian laser pulsations delivered (low=0 versus high grade=5852, P<0.001) were significantly higher in h

5 ients with cerebral gliomas (9 low-grade, 34 high-grade; 9 primary tumors, 34 recurrent tumors) who h

6 Median extraction time (low=0 versus high grade=97 seconds, P<0.001) and median laser pulsati

7 ow-grade ACLF in terms of risk of subsequent high-grade ACLF are unclear.

8 t in Apc(min) mice with increased numbers of high-grade adenomas.

9 oxicity tables that include the incidence of high-grade adverse events, defined by the Common Termino

10 reasonable regarding AAs' higher PHG, while high grade alone could not imply aggressiveness.

11 High-grade anal intraepithelial neoplasia (AIN2/3; HGAIN

12 of human papillomavirus (HPV) genotypes-and high-grade anal intraepithelial neoplasia (HGAIN) in men

13 a11/PDGFRbeta expression was associated with high grades and poorer clinical outcome in human BC pati

14 urse, and basal-like MDA-MB-231 connected to high-grade and aggressive disease.

15 otheliomas from these mice were consistently high-grade and invasive.

16 e molecular drivers of invasive progression, high-grade and metastatic disease are poorly defined.

17 Prognosis of patients with high-grade aneurysmal subarachnoid hemorrhage (aSAH) is

18 vels) in well characterized cohorts of human high-grade astrocytomas, mostly glioblastomas, compared

19 ogical and optical mapping studies indicated high-grade atrioventricular (A-V) block in ZO-1cKO compa

20 Delayed high-grade atrioventricular block (DH-AVB) has not been

21 High-grade atrioventricular block (H-AVB) is a well-desc

22 shock, sustained ventricular arrhythmia, and high-grade atrioventricular block within 30 days includi

23 e that can also efficiently bind B cells and high-grade B cell lymphoma (diffuse large B cell lymphom

24 d (NOS); 20 LBCL-IRF4 cases; and 12 cases of high-grade B-cell lymphoma (HGBCL), NOS in patients <=25

25 MHG defines a biologically coherent high-grade B-cell lymphoma group with distinct molecular

26 oups included diffuse large B-cell lymphoma, high-grade B-cell lymphoma with rearrangements of MYC an

27 In high-grade B-cell lymphoma, angiogenesis correlates with

28 High-grade B-cell lymphomas with MYC and BCL2 and/or BCL

29 n, it is an emerging precursor to neoplastic high-grade B-cell lymphoproliferation among people with

30 r, the ApoA1 concentrations of patients with high-grade BC were significantly higher than those of pa

31 Among high-grade brain tumors, glioblastoma is particularly di

32 iography (3.4% versus 10.2%, P<0.0001), have high-grade CAD (0.5% versus 6.5%, P<0.0001), and receive

33 The association between CAC and 90-day high-grade CAD and revascularization were assessed.

34 identifies PET/CT patients unlikely to have high-grade CAD or require revascularization within 90 da

35 on the percentage of (Gleason pattern-based) high-grade cancers (PHG) is demonstrated in EAs (p < 0.0

36 76% of the low-grade cancers and 71% of the high-grade cancers according to the consensus reading.

37 ipants were 1,904 prostate cancer cases (432 high-grade cancers) and 1,965 population controls.

38 eterogeneity in odds ratios between low- and high-grade cancers.

39 iency virus (HIV) plasma viral load (PVL) on high-grade cervical intraepithelial neoplasia (CIN2+) de

40 Overall, 28 high-grade cervical intraepithelial neoplasia (CIN3) cas

41 n papillomavirus (HPV) vaccine in preventing high-grade cervical lesions have been shown.

42 al effectiveness of qHPV vaccination against high-grade cervical precancerous lesions, among women va

43 Under conditions of high-grade chronic infection, we documented the presence

44 as the presence of residual and/or recurrent high-grade CIN2+/high-grade squamous intraepithelial les

45 lower continental crust may be strong under high-grade conditions.

46 tic intraepithelial lesion (n = 18, 38%) and high-grade conjunctival melanocytic intraepithelial lesi

47 graphy (PET/CT), is often used to assess for high-grade coronary artery disease (CAD) requiring revas

48 On the molecular level, low-grade and high-grade DCIS have different molecular alterations, an

49 ist1h3b(K27M) and Pik3ca(H1047R) to generate high-grade diffuse gliomas.

50 those with low-grade disease may progress to high-grade disease after immune modulation, which can be

51 Elevated Notch activity is associated with high-grade disease and metastasis.

52 ve immune surveillance of EBV, patients with high-grade disease may have a recurrence in the form of

53 e treatment with interferon-alpha2b, whereas high-grade disease requires immunochemotherapy.

54 mmune-dependent and typically polyclonal and high-grade disease to be immune-independent and typicall

55 ts with cN0 early breast cancer or extensive/high-grade ductal carcinoma in situ planned for standard

56 nce of UDD in predicting advanced neoplasia [high grade dysplasia or invasive carcinoma (HGD/IC)] was

57 of recurrent colonic adenoma associated with high-grade dysplasia (HGD) colon polyps at baseline colo

58 ty (HR 4.53, 95%CI 1.34-15.26; P = 0.02) and high-grade dysplasia (HGD) in the original resection (HR

59 BE patients at high risk for progression to high-grade dysplasia (HGD) or EAC are needed to improve

60 d 54 BE samples collected from patients with high-grade dysplasia (HGD) or esophageal adenocarcinoma

61 esection (ER) and ablation for patients with high-grade dysplasia (HGD) or intramucosal adenocarcinom

62 the preferred treatment for BE patients with high-grade dysplasia (HGD).

63 ssification based on adenoma size >=20 mm or high-grade dysplasia (instead of the current high-risk c

64 ratio [SIR] 2.07; 95% CI 1.40-2.93) or with high-grade dysplasia (SIR 0.79; 95% CI 0.39-1.41), where

65 ression in plasma EV of the 11 patients with high-grade dysplasia alone, only 1 had high MUC5AC expre

66 were 1.09 (95% CI, 0.85-1.33) for low-grade/high-grade dysplasia and 0.14 (95% CI, 0.06-0.22) for GC

67 over three years between the development of high-grade dysplasia and pancreatic cancer.

68 ntraductal papillary mucinous neoplasms with high-grade dysplasia and some enlarged pancreatic intrae

69 excision of advanced adenomas, diagnosis of high-grade dysplasia in the rectum or pouch, or progress

70 cholangitis) and no history of advanced CRN (high-grade dysplasia or colorectal cancer) or colectomy.

71 tion rates of lesions suspected of harboring high-grade dysplasia or early adenocarcinoma, a novel gr

72 a, with any or low-grade dysplasia, and with high-grade dysplasia were 60.8 years, 65.6 years, and 70

73 t adenomas, adenomas >=20 mm in diameter and high-grade dysplasia were associated with increased risk

74 omas (<1cm, and without villous histology or high-grade dysplasia) and no neoplasia, respectively (lo

75 ic lesions that include low-grade dysplasia, high-grade dysplasia, and adenocarcinomas.

76 or any adenoma with villous growth pattern, high-grade dysplasia, or >=10 mm in diameter).

77 mpared the development of pancreatic cancer, high-grade dysplasia, or clinically worrisome features,

78 s >=10mm, adenomas with villous histology or high-grade dysplasia, or colorectal cancer [CRC]) and as

79 ors for advanced colorectal neoplasia (aCRN, high-grade dysplasia, or CRC) in patients with IBD.

80 e cumulative incidence of pancreatic cancer, high-grade dysplasia, or worrisome features on pancreati

81 ith risk factors such has family history and high-grade dysplasia.

82 e with non-neoplastic disease and those with high-grade dysplasia/cancer with 72.1% of cases correctl

83 High-risk disease was defined as high-grade dysplasia/carcinoma.

84 ed detection rate of 100% (8/8) in detecting high-grade dysplasias and carcinomas over white-light de

85 Forty-five patients (83%) had high grade encephalopathy.

86 onal inactivation as a critical component of high-grade endometrial carcinoma disease pathogenesis.

87 -subunit gene PPP2R1A is highly prevalent in high-grade endometrial carcinoma.

88 Cervical biopsy showed high-grade endometrioid adenocarcinoma.

89 1 week history of diffuse abdominal pain and high grade fever, associated with vomiting and frequent

90 differentiate low-grade (Fuhrman I-II) from high-grade (Fuhrman III-IV) renal cell carcinoma using r

91 grade glioma (LGG) and all four subtypes of high grade glioma (GBM).

92 low-grade glioma (n = 93), ependymoma (32), high-grade glioma (25), medulloblastoma (22), gangliogli

93 (rCBV) and VSI(MRI) in eleven patients with high-grade glioma (7 WHO grade III and 4 WHO grade IV).

94 me, phosphoproteome and transcriptome in two high-grade glioma (HGG) mouse models driven by mutated R

95 Pediatric high-grade glioma (pHGG) and diffuse intrinsic pontine g

96 rate consistent and reproducible growth of a high-grade glioma in all animals.

97 High-grade glioma is the most common primary brain cance

98 ed metric maps derived from rs-fMRI) from 68 high-grade glioma patients with different survival time.

99 data from healthy fetal tissue and pediatric high-grade glioma patients, illustrates the potential of

100 progression and treatment-related changes in high-grade glioma patients.

101 rogression from treatment-related changes in high-grade glioma patients.

102 Response criteria for paediatric high-grade glioma vary historically and across different

103 group developed response criteria for adult high-grade glioma, but these were not created to meet th

104 recommendations for the management of adult high-grade glioma, for paediatrics there is inclusion of

105 response assessment criteria for paediatric high-grade glioma.

106 en shown to improve gross-total resection of high-grade glioma.

107 ssing intraoperative MRI in the treatment of high-grade glioma.

108 cost-effective modality in the treatment of high-grade glioma.

109 odel was constructed to follow patients with high-grade glioma.

110 ion is associated with favourable outcome in high-grade glioma.

111 treatment resistance rates, particularly for high grade gliomas, there is a need for specific biomark

112 High-grade gliomas (HGG) afflict both children and adult

113 Pediatric and adult high-grade gliomas (HGGs) frequently harbor PDGFRA alter

114 nant rhabdoid tumors (n = 229) and pediatric high-grade gliomas (n = 401), we show significant associ

115 metastatic cancers, including low-grade and high-grade gliomas and brain metastases (BrMs) originati

116 Pediatric high-grade gliomas are among the deadliest of childhood

117 High-grade gliomas are lethal brain cancers whose progre

118 High-grade gliomas are the most aggressive malignant bra

119 Posttreatment high-grade gliomas are usually monitored with contrast-e

120 High-grade gliomas defined by histone 3 K27M driver muta

121 Clinical trials of treatments for high-grade gliomas have traditionally relied on measures

122 present the molecular landscape of low- and high-grade gliomas in patients affected by NF1 (NF1-glio

123 and p53 pathways to induce the formation of high-grade gliomas in rodent models.

124 nges in assessing the response of paediatric high-grade gliomas to various treatments.

125 thods In this prospective study, adults with high-grade gliomas were enrolled between July 2015 and J

126 years +/- 12 [age range, 32-74 years]) with high-grade gliomas were included.

127 MRI accurately reflect vessel caliber within high-grade gliomas, while traditional measures of rCBV a

128 PET tracers for the treatment evaluation of high-grade gliomas.

129 r glioblastoma (GBM) results in formation of high-grade gliomas.

130 to current trials and clinical practice for high-grade gliomas.

131 existing tumor suppressor losses to generate high-grade gliomas.

132 High-grade (grades 3-5) injuries were less likely to res

133 d response rate and 95% CIs of all-grade and high-grade (>=3) adverse effects and evaluated the withi

134 rdiac CT detected 2 (1.4%) cases with DRT or high-grade HAT, respectively.

135 with DRT; and cardiac CT 6 (2.4%) cases with high-grade HAT.

136 High-grade HAT/DRT was associated with thromboembolism i

137 urces in the absence of sinks and sources of high-grade heat.

138 recipients receiving valganciclovir as PET, high-grade HHV-6 viremia was associated with increased a

139 survival among children and adolescents with high-grade, high-risk, mature B-cell non-Hodgkin's lymph

140 ll grades (low-grade, HR 0.38, P = 0.002 and high-grade, HR 0.62, P = 0.025) CONCLUSION:: PTR in GI-N

141 malignancy (NILM), and low-grade (LSIL) and high-grade (HSIL) squamous intraepithelial lesions.

142 those without preceding HTN, 17.7% developed high-grade HTN (BP >160/100 mm Hg).

143 al features was associated (P = 0.0002) with high-grade ICANS.

144 (WGS) and viral capture-based sequencing on high-grade immunohistochemically TAg-positive UCs in two

145 tic intraepithelial lesion from low-grade to high-grade in 2 (4%) of 47 cases.

146 e increased in synovia from OA patients with high grade inflammation.

147 High-grade injuries were more likely to progress than lo

148 lue in distinction between the low-grade and high-grade intraepithelial melanocytic proliferations an

149 l of evolution from borderline precursors to high-grade invasive MOC.

150 Family history of pancreatic cancer and high-grade IPMN was identified as risk factors for recur

151 greement in distinction between the low- and high-grade lesions was 76% for PAM, 67% for conjunctival

152 ot downgrade any of the histomorphologically high-grade lesions.

153 cidence correlates with a prior detection of high-grade lesions.

154 MUC5AC showed significantly higher levels in high-grade lesions.

155 h external beam radiotherapy (EBRT), whereas high-grade lymphomas (DLBCL and MCL) were treated with c

156 he newly phenotyped mutation C480F conferred high-grade maribavir resistance and low-grade ganciclovi

157 on its efficacy and safety in children with high-grade, mature B-cell non-Hodgkin's lymphoma are lim

158 ble model, the parameters most predictive of high-grade melanocytic intraepithelial lesion/melanoma i

159 the Mdm2 oncogene, which is correlated with high-grade, metastatic tumors.

160 ctivity in CO(2) hydrogenation and producing high-grade methanol.

161 (1) >=3 s electrical pause or asystole; (2) high-grade Mobitz type II atrioventricular block or comp

162 d with the majority of B-cell lymphomas with high-grade morphology tested.

163 Tumors displayed predominantly high-grade morphology with abundant granular eosinophili

164 e of the following five histologic subtypes: high-grade myxoid liposarcoma (HG-MLPS); leiomyosarcoma

165 fully differentiated normal human cells into high-grade NE tumors (Park et al. 2018.

166 preventative, and therapeutic approaches for high-grade NE tumors.

167 tissue sarcoma in children and represents a high-grade neoplasm of skeletal myoblast-like cells.

168 sults in a heterogeneous spectrum of low- to high-grade neoplasms occurring during the entire lifespa

169 ied patients with EGFR-mutant SCLC and other high-grade neuroendocrine carcinomas seen at our eight i

170 Here we describe murine models of high-grade neuroendocrine lung carcinomas generated by t

171 High-grade neuroendocrine lung malignancies (large-cell

172 e biopsy revealed a cytokeratin 20-positive, high-grade neuroendocrine neoplasm consistent with Merke

173 and CYR61 in liver tissues of patients with high-grade nonalcoholic steatohepatitis.

174 High-grade nonmuscle invasive bladder cancer (HRNMIBC) i

175 Poor baseline BCVA and high grade of opacity of the lesions were the composite

176 using 1,647 patients with resected localized high-grade or locally advanced disease (>= pT1b grade 3

177 the anastomosis, in the trunk (critical and high-grade), or in both sections.

178 intermediate (non-metastatic R0 or R1 >5 cm high-grade, or unresected tumour of any size or grade);

179 ma Study Group database with primary central high-grade osteosarcoma of the extremities, treated betw

180 d prognosis of patients with primary central high-grade osteosarcoma of the extremities.

181 pancreatic cancer involves visualisation of high-grade pancreatic intraepithelial neoplasias (PanIN-

182 pancreatic cancer involves visualization of high-grade pancreatic intraepithelial neoplasias (PanIN-

183 ti-gammaH2AX-TAT localizes preferentially in high-grade PanIN lesions but not in established PDAC.

184 reata, gammaH2AX expression was increased in high-grade PanINs but not in PDAC, corroborating earlier

185 reata, gammaH2AX expression was increased in high-grade PanINs, but not in PDAC, corroborating earlie

186 ice, which was correlated with the number of high-grade PanINs.

187 PC mice, which correlated with the number of high-grade PanINs.

188 High LAT1 was related to the high Grade, pathological T stage, LDH, and NLR.

189 that SOX9 is significantly overexpressed in high-grade PC tumors (P < 0.05) and in chemotherapy-trea

190 ted mutant p53-R270H to induce carcinoma and high grade pleomorphic sarcoma in FDXR(+/-); p53(R270H/-

191 heckpoints and suppressive interleukins from high-grade pre-invasive lesions; and, ultimately, (4) th

192 High-grade propylene and ethylene (>99.999%) can be gene

193 weeks, Frmd6/Pten double knockouts presented high-grade prostatic intraepithelial neoplasia (HG-PIN)

194 IDC-P could further be differentiated from high-grade prostatic intraepithelial neoplasia (HGPIN),

195 compound mice developed an earlier onset of high-grade prostatic intraepithelial neoplasia and accel

196 ereas age-matched Pten littermates developed high-grade prostatic intraepithelial neoplasia and prost

197 land is frequently and densely methylated in high-grade prostatic intraepithelial neoplasia, primary

198 Studies have documented AKI with high-grade proteinuria in patients with severe acute res

199 competence and short experimental times with high-grade read-outs when compared to conventional anima

200 onths 3, 6, and 9 was done in the absence of high-grade recurrence.

201 ary extravasation, which complicates ~30% of high-grade renal injuries.

202 he management of urinary extravasation after high-grade renal trauma, large, multi-institutional pros

203 leomorphic liposarcomas and nearly all other high-grade sarcomas.

204 =5852, P<0.001) were significantly higher in high-grade segments.

205 weeks after priming with a diverse Ag pool, high-grade sepsis was induced in C57BL/6j mice that was

206 High grade serous ovarian cancer (HGSOC) is a fatal gyne

207 High grade serous ovarian cancer (HGSOC) is the fifth le

208 and proliferation to predict the response of high grade serous ovarian cancer (HGSOC) to neoadjuvant

209 jor challenge for the clinical management of high grade serous ovarian cancer (HGSOC).

210 The cell-of-origin of high grade serous ovarian carcinoma (HGSOC) remains cont

211 n adult patients (>=18 years) with relapsed, high-grade serous (grade 2 or 3) epithelial ovarian, fal

212 umor cells derived from malignant ascites of high-grade serous adenocarcinoma patients.

213 Robust preclinical models of ovarian high-grade serous carcinoma (HGSC) are needed to advance

214 Tumors of the high-grade serous carcinoma (HGSC) type represent the mo

215 High-grade serous carcinoma (HGSC), an epithelial cancer

216 The prevailing paradigm in the genesis of high-grade serous carcinoma (HGSC), the most common ovar

217 High-grade serous carcinoma has a poor prognosis, owing

218 roprotein convertase, is highly expressed in high-grade serous carcinoma of ovarian cancer patients,

219 High-grade serous carcinoma, accounts for up to 70% of a

220 a closely mirror those of human tubo-ovarian high-grade serous carcinoma.

221 Many high-grade serous carcinomas (HGSCs) likely originate in

222 hich the cell lines were derived, given that high-grade serous carcinomas typically expand and spread

223 en I substrates than cell lines derived from high-grade serous carcinomas.

224 first-line, platinum-based chemotherapy with high-grade serous or endometrioid EOC should be offered

225 8 years or older who had platinum-sensitive, high-grade serous or endometrioid ovarian, primary perit

226 years or older with measurable or evaluable high-grade serous or endometrioid platinum-sensitive rec

227 18 years) with recurrent, platinum-resistant high-grade serous ovarian cancer (determined histologica

228 ) frequently develops in women with advanced high-grade serous ovarian cancer (HGSOC) and is associat

229 sought to identify susceptibility genes for high-grade serous ovarian cancer (HGSOC) by performing a

230 roteins that are differentially expressed in high-grade serous ovarian cancer (HGSOC) cell lines comp

231 Emerging evidence has indicated that high-grade serous ovarian cancer (HGSOC) originates in t

232 case-control study of advanced and recurrent high-grade serous ovarian cancer (HGSOC) patients in whi

233 nd during neoadjuvant chemotherapy (NACT) in high-grade serous ovarian cancer (HGSOC), we performed i

234 leading cause of morbidity and mortality in high-grade serous ovarian cancer (HGSOC).

235 se heritability (h(g)(2)) of EOC overall and high-grade serous ovarian cancer (HGSOCs) were estimated

236 sis of tumor microenvironment composition in high-grade serous ovarian cancer and follicular lymphoma

237 breast cancer patient-derived xenografts and high-grade serous ovarian cancer cell lines and discover

238 2 is functionally silenced, HR+, CARM1-high, high-grade serous ovarian cancer cells become PARPi sens

239 peats (CRISPR)-mediated knockout of FABP4 in high-grade serous ovarian cancer cells reduced metastati

240 High-grade serous ovarian cancer patient tumors and cell

241 n the fallopian tubes (the site of origin of high-grade serous ovarian cancer), and whether such chan

242 In high-grade serous ovarian cancer, Galgo signatures obtai

243 rategy to selectively target BRCA1-deficient high-grade serous ovarian cancer, which is characterized

244 nd superior efficacy to gemcitabine alone in high-grade serous ovarian cancer.

245 regimen and overcome platinum resistance in high-grade serous ovarian cancer.

246 osertib to gemcitabine in platinum-resistant high-grade serous ovarian cancer.

247 ologous recombination (HR) repair defects in high-grade serous ovarian cancers (HGSOCs).

248 High-grade serous ovarian cancers show increased replica

249 coexist within the CD49e+ CAF compartment in high-grade serous ovarian cancers.

250 High-grade serous ovarian carcinoma (HGSC), the most com

251 rotein glycosylation in the heterogeneity of high-grade serous ovarian carcinoma (HGSC), we perform m

252 High-grade serous ovarian carcinoma (HGSOC) is the most

253 High-grade serous ovarian carcinoma (HGSOC) is the most

254 es have identified transcriptome subtypes of high-grade serous ovarian carcinoma (HGSOC), but their i

255 High-grade serous ovarian carcinoma commonly arises from

256 High-grade serous ovarian carcinoma is characterised by

257 n is expressed in many carcinomas, including high-grade serous ovarian carcinoma, where it contribute

258 or lesion, respectively, for the majority of high-grade serous ovarian carcinomas (HGSOC) provide the

259 ar findings were observed when restricted to high-grade serous tumors.

260 ogy and Obstetrics (FIGO; 1988) stage IC-IIA high-grade serous, clear cell, or any poorly differentia

261 en aged 18 years and older with stage III/IV high-grade serous, endometrioid, or clear cell ovarian c

262 orrelated with better survival (p = 0.01) in high-grade serous.

263 ctal carcinomas in situ (88% intermediate or high grade [seven of eight]) and 18 invasive cancers (14

264 L (LSIL) at baseline, risk of progression to high-grade SIL (HSIL) and the clearance rate were estima

265 rus (HR-HPV) testing to predict histological high-grade SILs (hHSILs).

266 ILs) at baseline, the risk of progression to high-grade SILs (HSILs) and the clearance rate were esti

267 may offer benefit, especially in areas with high-grade SP resistance.

268 first lentiviral vector induced pig model of high-grade spinal cord glioma and may potentially be use

269 present study, we report the production of a high-grade spinal cord glioma model in pigs using lentiv

270 cord glioma (SCG) patients, particularly in high-grade spinal gliomas (Grade IV) known as glioblasto

271 In addition, we show that high-grade spiradenocarcinomas carry loss-of-function TP

272 analysis were conducted with histologic anal high-grade squamous intraepithelial lesion (A-HSIL) as t

273 y and specificity for a combined endpoint of high-grade squamous intraepithelial lesion (HSIL) and an

274 aharan Africa, are at high risk for cervical high-grade squamous intraepithelial lesions (HSIL) and c

275 pathology-predict anal HPV16 infection, anal high-grade squamous intraepithelial lesions (HSIL) and,

276 rological and serological predictors of anal high-grade squamous intraepithelial lesions (HSIL) in hu

277 s Terminology (LAST) in low-grade (LSIL) and high-grade squamous intraepithelial lesions (HSIL), and

278 Anal high-grade squamous intraepithelial lesions (HSILs) abla

279 Anal high-grade squamous intraepithelial lesions (HSILs) prec

280 f residual and/or recurrent high-grade CIN2+/high-grade squamous intraepithelial lesions post-treatme

281 %), with 4.7% (95% CI, 2.5%-8.5%; I(2) = 0%) high-grade squamous intraepithelial lesions.

282 he outcomes after liver transplantation with high-grade steatotic livers.

283 entify MRI features that are associated with high-grade STS (grade III) and to determine the relation

284 High-grade T1 (HGT1) bladder cancer is the highest risk

285 ts with carcinoma in situ (with or without a high-grade Ta or T1 tumour) had a complete response with

286 ts with carcinoma in situ (with or without a high-grade Ta or T1 tumour).

287 In the tumor region, CMRO(2) was reduced (high-grade tumor CMRO(2), 0.23 mumol/g/min +/- 0.07; low

288 single sub-network that is perturbed in all high-grade tumor regions.

289 molecular advances, the clinical outcomes of high grade tumors, including H3K27M diffuse midline glio

290 ogress, leading to high expression levels in high-grade tumors and metastases.

291 metastasis, and specifically associated with high-grade tumors and poor prognoses in breast cancers.

292 High-grade tumors harbored genetic alterations of TP53 a

293 e tumors have a higher mortality rate, while high-grade tumors have a better outcome.

294 gallium 68 DOTATATE PET/CT, and in cases of high-grade tumors, they were also evaluated with fluorin

295 -metastatic R0 or R1 low-grade, or <=5 cm R1 high-grade tumour); intermediate (non-metastatic R0 or R

296 mphovascular invasion, hydronephrosis and/or high-grade upper tract disease(3-5).

297 papillomavirus-16 incidence was higher among high-grade versus no lesion at baseline (adjusted incide

298 High-grade viremia was independently associated with bio

299 (p=0.029) were significantly associated with high-grade viremia.

300 f diffuse infiltrating gliomas, particularly high grade, which leads to a potential treatment delay f